Balaxi Pharmaceuticals consolidated net profit declines 68.19% in the September 2024 quarter

Net profit of Balaxi Pharmaceuticals declined 68.19% to Rs 4.59 crore in the quarter ended September 2024 as against Rs 14.43 crore during the previous quarter ended September 2023. Sales rose 41.41% to Rs 77.38 crore in the quarter ended September 2024 as against Rs 54.72 crore during the previous quarter ended September 2023.

Particulars	Quarter Ended
	Sep. 2024	Sep. 2023	% Var.
Sales	77.38	54.72	41
OPM %	13.69	19.66	-
PBDT	6.03	10.67	-43
PBT	5.56	10.01	-44
NP	4.59	14.43	-68